IRIS UniCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.515
EU - Europa 8.022
AS - Asia 7.205
SA - Sud America 1.384
AF - Africa 226
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 25
AN - Antartide 1
Totale 27.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.243
SG - Singapore 3.366
DE - Germania 2.018
CN - Cina 1.710
BR - Brasile 1.113
SE - Svezia 1.103
IT - Italia 1.001
FR - Francia 916
PL - Polonia 780
UA - Ucraina 683
VN - Vietnam 606
IE - Irlanda 384
GB - Regno Unito 351
IN - India 318
ID - Indonesia 256
FI - Finlandia 239
RU - Federazione Russa 196
HK - Hong Kong 160
CA - Canada 137
TR - Turchia 137
JP - Giappone 126
BD - Bangladesh 107
AR - Argentina 103
BE - Belgio 89
IQ - Iraq 79
MX - Messico 74
ZA - Sudafrica 68
NL - Olanda 45
IR - Iran 40
VE - Venezuela 38
PK - Pakistan 37
SA - Arabia Saudita 36
EC - Ecuador 33
ES - Italia 32
CO - Colombia 28
AU - Australia 27
CI - Costa d'Avorio 27
MA - Marocco 27
AT - Austria 26
KR - Corea 25
CL - Cile 22
CH - Svizzera 19
JO - Giordania 19
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
EG - Egitto 16
KE - Kenya 16
LT - Lituania 16
RO - Romania 15
TN - Tunisia 15
IL - Israele 14
NP - Nepal 14
PH - Filippine 14
AZ - Azerbaigian 13
DZ - Algeria 13
UY - Uruguay 13
BO - Bolivia 12
EU - Europa 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
DK - Danimarca 11
JM - Giamaica 11
HN - Honduras 10
KG - Kirghizistan 10
PY - Paraguay 10
AL - Albania 9
GR - Grecia 9
MY - Malesia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BG - Bulgaria 8
ET - Etiopia 8
LK - Sri Lanka 8
PA - Panama 8
PT - Portogallo 8
NO - Norvegia 7
OM - Oman 7
SN - Senegal 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
KH - Cambogia 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
LV - Lettonia 6
NG - Nigeria 6
TH - Thailandia 6
AM - Armenia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
AO - Angola 4
EE - Estonia 4
GE - Georgia 4
MM - Myanmar 4
SC - Seychelles 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GH - Ghana 3
KW - Kuwait 3
KZ - Kazakistan 3
Totale 27.346
Salva come PNG Salva come JPEG
Città #
Singapore 1.743
Chandler 1.287
Ashburn 1.025
San Jose 814
Warsaw 627
Ann Arbor 390
Jacksonville 390
Dearborn 371
Dublin 366
San Mateo 318
Beijing 306
Wilmington 288
Fairfield 273
Nanjing 250
Woodbridge 238
Jakarta 234
New York 199
Ho Chi Minh City 198
Lauterbourg 195
Houston 188
Los Angeles 187
Seattle 179
Cattolica 178
Boston 173
Hanoi 163
Munich 154
Hong Kong 150
Lawrence 140
Kraków 121
Milan 116
Hefei 107
Moscow 106
Frankfurt am Main 101
Rome 100
Dallas 99
The Dalles 98
Tokyo 98
Chicago 97
São Paulo 94
Redwood City 92
Bremen 91
Marseille 86
Cambridge 83
Izmir 83
Brussels 82
Nürnberg 81
Nanchang 76
Princeton 68
Buffalo 66
Santa Clara 63
Kunming 61
Boardman 60
Helsinki 59
Lancaster 57
Norwalk 57
Pune 56
Orem 52
Mountain View 50
Guangzhou 46
Hebei 46
London 44
Shenyang 43
Tianjin 39
University Park 37
Hangzhou 36
Shanghai 36
Redmond 35
Toronto 35
Council Bluffs 34
Paris 34
Baghdad 33
Da Nang 33
Falls Church 31
Montreal 31
Denver 30
Johannesburg 30
Phoenix 29
Atlanta 28
Chennai 28
Detroit 28
Jiaxing 27
Abidjan 26
Brooklyn 26
Changsha 26
Nuremberg 26
Rio de Janeiro 25
Zhengzhou 24
Fremont 23
San Francisco 23
Brasília 22
Jinan 22
Stockholm 22
Belo Horizonte 21
Dhaka 21
Kent 21
Leawood 21
Seoul 21
Turku 21
Andover 20
Augusta 20
Totale 14.708
Salva come PNG Salva come JPEG
Nome #
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 440
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 440
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 357
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 347
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 344
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 318
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 307
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 265
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 260
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 257
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 245
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 228
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 225
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 224
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 216
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 214
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 209
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 209
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 206
Septic sacroiliitis: an uncommon septic arthritis 205
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 203
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 199
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 198
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 197
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 196
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 195
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 194
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 191
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 188
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 185
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 184
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 183
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 182
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 181
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 181
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 180
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 176
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 173
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 173
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 170
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 170
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 167
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 167
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 166
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 164
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 162
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 161
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 159
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 157
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 157
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 156
Preliminary classification criteria for the cryoglobulinaemic vasculitis 153
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 148
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 148
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 146
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 146
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 144
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 142
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 141
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 140
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 140
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 140
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 137
New therapeutic effects of cilostazol in patients with ischemic disorders. 136
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 135
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 133
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 132
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 132
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 131
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 127
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 127
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 127
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 127
Immune-Guided Therapy of COVID-19 126
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 124
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 123
Artrite reumatoide. Terapia 123
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 123
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 122
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 121
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 120
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 120
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 120
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 120
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 115
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 115
Polimialgia reumatica ed arterite temporale di Horton 115
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 115
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 115
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 115
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 114
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 114
Totale 17.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20253.291 73 93 294 118 323 87 75 165 526 293 633 611
2025/20268.610 1.516 288 485 871 1.513 467 1.622 390 518 609 254 77
Totale 27.765